[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Point of Care Diagnostic Market: Size, Trend, Share, Opportunity Analysis & Forecast, 2014–2025

February 2017 | | ID: G2DB5C854B7EN
Progressive Markets (owned by Antviews Global)

US$ 3,619.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Point of care (POC) diagnostic testing is also called as bedside testing. This is a type of medical testing carried out at the time of patient care in a physician’s office, at home, in an ambulance, or in the hospital. The global point of care diagnostic market is expected to grow at a CAGR of 9.4% from 2017 to 2025.

Based on product type, the market is divided into Glucose Monitoring Kits, Cardiometabolic Monitoring Kits, Infectious Diseases Testing Kits, Coagulation Monitoring Kits, Pregnancy and Fertility Testing Kits, Tumor/Cancer Markers, Urinalysis Testing Kits, Cholesterol Test Strips, Hematology Testing Kits, Drugs of Abuse Testing Kits, Fecal Occult Testing Kits, and Others. According to prescription mode, the market is divided into prescription-based testing kits and over the counter testing kits. The end-user segment is bifurcated into professional diagnostic centers, research laboratories, home care, and other end users. Geographic breakdown and deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and LAMEA.

MARKET DYNAMICS:

Drivers:
  • Technological advancements of point of care diagnostics.
  • Rising incidence of chronic diseases and increase in awareness about early diagnosis of diseases.
  • Increase in demand for home based diagnostic methods.
  • Rise in investment by the government for the modernization and advancement of the healthcare reforms.
Restraints:
      • Pricing pressure is expected to restrain the market as POC devices are highly costly.
MARKET PLAYERS:

The top players in the global point of care diagnostics market include Roche Diagnostics Limited, Abbott Laboratories, Inc., Siemens AG, Becton, Alere Inc., Dickinson and Company, Beckman Coulter, Inc., Johnson & Johnson, PTS Diagnostics, and Nova Biomedical.

KEY TAKEAWAYS

MARKET LANDSCAPE
  • By Product
      • Glucose Monitoring Kits
      • Cardiometabolic Monitoring Kits
    • Cardiac Markers
    • Lipids Testing
    • Blood Gas/Electrolytes Testing Kits
    • HbA1c Testing Kits
      • Infectious Diseases Testing Kits
    • Influenza Testing Kits
    • HIV Testing Kits
    • Hepatitis C Testing Kits
    • Sexually-transmitted Diseases (STDs) Testing Kits
    • Tropical Diseases Testing Kits
    • Healthcare-associated Infections (HAIs)
    • Respiratory Infections Testing Kits
    • Others
      • Coagulation Monitoring Kits
    • Prothrombin Time (PT/INR) Testing Kits
    • Activated Clotting Time (ACT/APTT) Testing Kits
      • Pregnancy and Fertility Testing Kits
    • Pregnancy Testing Kits
    • Fertility Testing Kits
      • Tumor/Cancer Markers
      • Urinalysis Testing Kits
      • Cholesterol Test Strips
      • Hematology Testing Kits
      • Drugs of Abuse Testing Kits
      • Fecal Occult Testing Kits
      • Others
  • By Prescription Mode
      • Prescription-based Testing Kits
      • Over-the-counter (OTC) Testing Kits
  • By End User
      • Professional Diagnostic Centers
    • Hospitals/Critical Care Centers
    • Outpatient Healthcare Settings
    • Ambulatory Care Settings
      • Research Laboratories
      • Home Care
      • Other End Users
  • By Geography
      • North America
    • U.S.
    • Canada
    • Mexico
      • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
      • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
      • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
1. EXECUTIVE SUMMARY

1.1. Key findings
1.2. Market attractiveness and trend analysis
1.3. Competitive landscape and recent industry development analysis

2. INTRODUCTION

2.1. Report description
2.2. Scope and definitions
2.3. Research methodology

3. MARKET LANDSCAPE

3.1. Growth drivers
  3.1.1. Impact analysis
3.2. Restrains and challenges
  3.2.1. Impact analysis
3.3. Porter’s analysis
  3.3.1. Bargaining power of buyers
  3.3.2. Bargaining power of suppliers
  3.3.3. Threat of substitutes
  3.3.4. Industry rivalry
  3.3.5. Threat of new entrants
3.4. Global point of care diagnostic market shares analysis, 2014-2025
  3.4.1. Global point of care diagnostic market share by product, 2014-2025
  3.4.2. Global point of care diagnostic market share by prescription mode, 2014-2025
  3.4.3. Global point of care diagnostic market share by end-user, 2014-2025
  3.4.4. Global point of care diagnostic market share by geography, 2014-2025

4. POINT OF CARE DIAGNOSTIC MARKET BY PRODUCT

4.1. Glucose monitoring kits
  4.1.1. Historical market size by region, 2014-2016
  4.1.2. Market forecast by region, 2017-2025
4.2. Cardiometabolic monitoring kits
  4.2.1. Historical market size by region, 2014-2016
  4.2.2. Market forecast by region, 2017-2025
  4.2.3. Cardiac markers
    4.2.3.1. Historical market size by region, 2014-2016
    4.2.3.2. Market forecast by region, 2017-2025
  4.2.4. Lipids testing
    4.2.4.1. Historical market size by region, 2014-2016
    4.2.4.2. Market forecast by region, 2017-2025
  4.2.5. Blood gas/electrolytes testing kits
    4.2.5.1. Historical market size by region, 2014-2016
    4.2.5.2. Market forecast by region, 2017-2025
  4.2.6. Hba1c testing kits
    4.2.6.1. Historical market size by region, 2014-2016
    4.2.6.2. Market forecast by region, 2017-2025
4.3. Infectious diseases testing kits
  4.3.1. Historical market size by region, 2014-2016
  4.3.2. Market forecast by region, 2017-2025
  4.3.3. Influenza testing kits
    4.3.3.1. Historical market size by region, 2014-2016
    4.3.3.2. Market forecast by region, 2017-2025
  4.3.4. Hiv testing kits
    4.3.4.1. Historical market size by region, 2014-2016
    4.3.4.2. Market forecast by region, 2017-2025
  4.3.5. Hepatitis c testing kits
    4.3.5.1. Historical market size by region, 2014-2016
    4.3.5.2. Market forecast by region, 2017-2025
  4.3.6. Sexually-transmitted diseases (stds) testing kits
    4.3.6.1. Historical market size by region, 2014-2016
    4.3.6.2. Market forecast by region, 2017-2025
  4.3.7. Tropical diseases testing kits
    4.3.7.1. Historical market size by region, 2014-2016
    4.3.7.2. Market forecast by region, 2017-2025
  4.3.8. Healthcare-associated infections (hais)
    4.3.8.1. Historical market size by region, 2014-2016
    4.3.8.2. Market forecast by region, 2017-2025
  4.3.9. Respiratory infections testing kits
    4.3.9.1. Historical market size by region, 2014-2016
    4.3.9.2. Market forecast by region, 2017-2025
  4.3.10. Others
    4.3.10.1. Historical market size by region, 2014-2016
    4.3.10.2. Market forecast by region, 2017-2025
4.4. Coagulation monitoring kits
  4.4.1. Historical market size by region, 2014-2016
  4.4.2. Market forecast by region, 2017-2025
  4.4.3. Prothrombin time (pt/inr) testing kits
    4.4.3.1. Historical market size by region, 2014-2016
    4.4.3.2. Market forecast by region, 2017-2025
  4.4.4. Activated clotting time (act/aptt) testing kits
    4.4.4.1. Historical market size by region, 2014-2016
    4.4.4.2. Market forecast by region, 2017-2025
4.5. Pregnancy and fertility testing kits
  4.5.1. Historical market size by region, 2014-2016
  4.5.2. Market forecast by region, 2017-2025
  4.5.3. Pregnancy testing kits
    4.5.3.1. Historical market size by region, 2014-2016
    4.5.3.2. Market forecast by region, 2017-2025
  4.5.4. Fertility testing kits
    4.5.4.1. Historical market size by region, 2014-2016
    4.5.4.2. Market forecast by region, 2017-2025
4.6. Tumor/cancer markers
  4.6.1. Historical market size by region, 2014-2016
  4.6.2. Market forecast by region, 2017-2025
4.7. Urinalysis testing kits
  4.7.1. Historical market size by region, 2014-2016
  4.7.2. Market forecast by region, 2017-2025
4.8. Cholesterol test strips
  4.8.1. Historical market size by region, 2014-2016
  4.8.2. Market forecast by region, 2017-2025
4.9. Hematology testing kits
  4.9.1. Historical market size by region, 2014-2016
  4.9.2. Market forecast by region, 2017-2025
4.10. Drugs of abuse testing kits
  4.10.1. Historical market size by region, 2014-2016
  4.10.2. Market forecast by region, 2017-2025
4.11. Fecal occult testing kits
  4.11.1. Historical market size by region, 2014-2016
  4.11.2. Market forecast by region, 2017-2025
4.12. Others
  4.12.1. Historical market size by region, 2014-2016
  4.12.2. Market forecast by region, 2017-2025

5. POINT OF CARE DIAGNOSTIC MARKET BY PRESCRIPTION MODE

5.1. Prescription-based testing kits
  5.1.1. Historical market size by region, 2014-2016
  5.1.2. Market forecast by region, 2017-2025
5.2. Over-the-counter (otc) testing kits
  5.2.1. Historical market size by region, 2014-2016
  5.2.2. Market forecast by region, 2017-2025

6. POINT OF CARE DIAGNOSTIC MARKET BY END-USER

6.1. Professional diagnostic centers
  6.1.1. Historical market size by region, 2014-2016
  6.1.2. Market forecast by region, 2017-2025
  6.1.3. Hospitals/critical care centers
    6.1.3.1. Historical market size by region, 2014-2016
    6.1.3.2. Market forecast by region, 2017-2025
  6.1.4. Outpatient healthcare settings
    6.1.4.1. Historical market size by region, 2014-2016
    6.1.4.2. Market forecast by region, 2017-2025
  6.1.5. Ambulatory care settings
    6.1.5.1. Historical market size by region, 2014-2016
    6.1.5.2. Market forecast by region, 2017-2025
6.2. Research laboratories
  6.2.1. Historical market size by region, 2014-2016
  6.2.2. Market forecast by region, 2017-2025
6.3. Home care
  6.3.1. Historical market size by region, 2014-2016
  6.3.2. Market forecast by region, 2017-2025
6.4. Other end users
  6.4.1. Historical market size by region, 2014-2016
  6.4.2. Market forecast by region, 2017-2025

7. POINT OF CARE DIAGNOSTIC MARKET BY GEOGRAPHY

7.1. North America
  7.1.1. U.S.
    7.1.1.1. Historical market size, 2014-2016
    7.1.1.2. Market forecast, 2017-2025
  7.1.2. Canada
    7.1.2.1. Historical market size, 2014-2016
    7.1.2.2. Market forecast, 2017-2025
  7.1.3. Mexico
    7.1.3.1. Historical market size, 2014-2016
    7.1.3.2. Market forecast, 2017-2025
7.2. Europe
  7.2.1. UK
    7.2.1.1. Historical market size, 2014-2016
    7.2.1.2. Market forecast, 2017-2025
  7.2.2. Germany
    7.2.2.1. Historical market size, 2014-2016
    7.2.2.2. Market forecast, 2017-2025
  7.2.3. France
    7.2.3.1. Historical market size, 2014-2016
    7.2.3.2. Market forecast, 2017-2025
  7.2.4. Spain
    7.2.4.1. Historical market size, 2014-2016
    7.2.4.2. Market forecast, 2017-2025
  7.2.5. Italy
    7.2.5.1. Historical market size, 2014-2016
    7.2.5.2. Market forecast, 2017-2025
  7.2.6. Rest of Europe
    7.2.6.1. Historical market size, 2014-2016
    7.2.6.2. Market forecast, 2017-2025
7.3. Asia-Pacific
  7.3.1. China
    7.3.1.1. Historical market size, 2014-2016
    7.3.1.2. Market forecast, 2017-2025
  7.3.2. Japan
    7.3.2.1. Historical market size, 2014-2016
    7.3.2.2. Market forecast, 2017-2025
  7.3.3. India
    7.3.3.1. Historical market size, 2014-2016
    7.3.3.2. Market forecast, 2017-2025
  7.3.4. Australia
    7.3.4.1. Historical market size, 2014-2016
    7.3.4.2. Market forecast, 2017-2025
  7.3.5. South Korea
    7.3.5.1. Historical market size, 2014-2016
    7.3.5.2. Market forecast, 2017-2025
  7.3.6. Rest of Asia-Pacific
    7.3.6.1. Historical market size, 2014-2016
    7.3.6.2. Market forecast, 2017-2025
7.4. LAMEA
  7.4.1. Brazil
    7.4.1.1. Historical market size, 2014-2016
    7.4.1.2. Market forecast, 2017-2025
  7.4.2. Saudi Arabia
    7.4.2.1. Historical market size, 2014-2016
    7.4.2.2. Market forecast, 2017-2025
  7.4.3. South Africa
    7.4.3.1. Historical market size, 2014-2016
    7.4.3.2. Market forecast, 2017-2025
  7.4.4. Rest of LAMEA
    7.4.4.1. Historical market size, 2014-2016
    7.4.4.2. Market forecast, 2017-2025

8. COMPANY PROFILES

8.1. Roche diagnostics limited
  8.1.1. Overview
  8.1.2. Financials and business segments
  8.1.3. Recent developments
8.2. Abbott laboratories, inc.
  8.2.1. overview
  8.2.2. Financials and business segments
  8.2.3. Recent developments
8.3. Siemens ag
  8.3.1. Overview
  8.3.2. Financials and business segments
  8.3.3. Recent developments
8.4. Becton
  8.4.1. overview
  8.4.2. Financials and business segments
  8.4.3. Recent developments
8.5. Alere inc.
  8.5.1. Overview
  8.5.2. Financials and business segments
  8.5.3. Recent developments
8.6. Beckman coulter, inc.
  8.6.1. overview
  8.6.2. Financials and business segments
  8.6.3. Recent developments
8.7. Becton, dickinson and company
  8.7.1. Overview
  8.7.2. Financials and business segments
  8.7.3. Recent developments
8.8. Johnson & johnson
  8.8.1. overview
  8.8.2. Financials and business segments
  8.8.3. Recent developments
8.9. Pts diagnostics
  8.9.1. Overview
  8.9.2. Financials and business segments
  8.9.3. Recent developments
8.10. Nova biomedical
  8.10.1. Overview
  8.10.2. Financials and business segments
  8.10.3. Recent developments

LIST OF TABLES

Table 1. Point of Care Diagnostic Market Share, by Product, 2014-2025
Table 2. Point of Care Diagnostic Market Share, by Prescription Mode, 2014-2025
Table 3. Point of Care Diagnostic Market Share, by End-User, 2014-2025
Table 4. Point of Care Diagnostic Market Share, by Region, 2014-2025
Table 5. Point of Care Diagnostic Market Value for Glucose Monitoring Kits, by Region, 2017-2025, $million
Table 6. Point of Care Diagnostic Market Value for Cardiometabolic Monitoring Kits, by Type, 2014-2025, $million
Table 7. Point of Care Diagnostic Market Value for Cardiometabolic Monitoring Kits, by Region, 2017-2025, $million
Table 8. Point of Care Diagnostic Market Value for Cardiac Markers, by Region, 2017-2025, $million
Table 9. Point of Care Diagnostic Market Value for Lipids Testing, by Region, 2017-2025, $million
Table 10. Point of Care Diagnostic Market Value for Blood Gas/Electrolytes Testing Kits, by Region, 2017-2025, $million
Table 11. Point of Care Diagnostic Market Value for HbA1c Testing Kits, by Region, 2017-2025, $million
Table 12. Point of Care Diagnostic Market Value for Infectious Diseases Testing Kits, by Type, 2014-2025, $million
Table 13. Point of Care Diagnostic Market Value for Infectious Diseases Testing Kits, by Region, 2017-2025, $million
Table 14. Point of Care Diagnostic Market Value for Influenza Testing Kits, by Region, 2017-2025, $million
Table 15. Point of Care Diagnostic Market Value for HIV Testing Kits, by Region, 2017-2025, $million
Table 16. Point of Care Diagnostic Market Value for Hepatitis C Testing Kits, by Region, 2017-2025, $million
Table 17. Point of Care Diagnostic Market Value for Sexually-transmitted Diseases (STDs) Testing Kits, by Region, 2017-2025, $million
Table 18. Point of Care Diagnostic Market Value for Tropical Diseases Testing Kits, by Region, 2017-2025, $million
Table 19. Point of Care Diagnostic Market Value for Healthcare-associated Infections (HAIs), by Region, 2017-2025, $million
Table 20. Point of Care Diagnostic Market Value for Respiratory Infections Testing Kits, by Region, 2017-2025, $million
Table 21. Point of Care Diagnostic Market Value for Other Infectious Diseases Testing Kits, by Region, 2017-2025, $million
Table 22. Point of Care Diagnostic Market Value for Coagulation Monitoring Kits, by Type, 2014-2025, $million
Table 24. Point of Care Diagnostic Market Value for Prothrombin Time (PT/INR) Testing Kits, by Region, 2017-2025, $million
Table 25. Point of Care Diagnostic Market Value for Activated Clotting Time (ACT/APTT) Testing Kits, by Region, 2017-2025, $million
Table 26. Point of Care Diagnostic Market Value for Pregnancy and Fertility Testing Kits, by Type, 2014-2025, $million
. Point of Care Diagnostic Market Value for Pregnancy and Fertility Testing Kits, by Region, 2014-2025, $million
Table 27. Point of Care Diagnostic Market Value for Pregnancy Testing Kits, by Region, 2017-2025, $million
Table 28. Point of Care Diagnostic Market Value for Fertility Testing Kits, by Region, 2017-2025, $million
Table 29. Point of Care Diagnostic Market Value for Tumor/Cancer Markers, by Region, 2017-2025, $million
Table 30. Point of Care Diagnostic Market Value for Urinalysis Testing Kits, by Region, 2017-2025, $million
Table 31. Point of Care Diagnostic Market Value for Cholesterol Test Strips, by Region, 2017-2025, $million
Table 32. Point of Care Diagnostic Market Value for Hematology Testing Kits, by Region, 2017-2025, $million
Table 33. Point of Care Diagnostic Market Value for Drugs of Abuse Testing Kits, by Region, 2017-2025, $million
Table 34. Point of Care Diagnostic Market Value for Fecal Occult Testing Kits, by Region, 2017-2025, $million
Table 35. Point of Care Diagnostic Market Value for Other Products, by Region, 2017-2025, $million
Table 36. Point of Care Diagnostic Market Value for Prescription-based Testing Kits, by Region, 2017-2025, $million
Table 37. Point of Care Diagnostic Market Value for Over-the-counter (OTC) Testing Kits, by Region, 2017-2025, $million
Table 38. Point of Care Diagnostic Market Value for Professional Diagnostic Centers, by Type, 2014-2025, $million
Table 39. Point of Care Diagnostic Market Value for Professional Diagnostic Centers, by Region, 2017-2025, $million
Table 40. Point of Care Diagnostic Market Value for Hospitals/Critical Care Centers, by Region, 2017-2025, $million
Table 41. Point of Care Diagnostic Market Value for Outpatient Healthcare Settings, by Region, 2017-2025, $million
Table 42. Point of Care Diagnostic Market Value for Ambulatory Care Settings, by Region, 2017-2025, $million
Table 43. Point of Care Diagnostic Market Value for Research Laboratories , by Region, 2017-2025, $million
Table 44. Point of Care Diagnostic Market Value for Home Care, by Region, 2017-2025, $million
Table 45. Point of Care Diagnostic Market Value for Other End Users, by Region, 2017-2025, $million
Table 46. Point of Care Diagnostic Market Value for North America, by Country, 2014-2025, $million
Table 47. Point of Care Diagnostic Market Value for North America, by Type, 2014-2025, $million
Table 48. Point of Care Diagnostic Market Value for North America, by Application, 2014-2025, $million
Table 49. Point of Care Diagnostic Market Value for Europe, by Country, 2014-2025, $million
Table 50. Point of Care Diagnostic Market Value for Europe, by Type, 2014-2025, $million
Table 51. Point of Care Diagnostic Market Value for Europe, by Application, 2014-2025, $million
Table 52. Point of Care Diagnostic Market Value for Asia-Pacific, by Country, 2014-2025, $million
Table 53. Point of Care Diagnostic Market Value for Asia-Pacific, by Type, 2014-2025, $million
Table 54. Point of Care Diagnostic Market Value for Asia-Pacific, by Application, 2014-2025, $million
Table 55. Point of Care Diagnostic Market Value for LAMEA, by Country, 2014-2025, $million
Table 56. Point of Care Diagnostic Market Value for LAMEA, by Type, 2014-2025, $million
Table 57. Point of Care Diagnostic Market Value for LAMEA, by Application, 2014-2025, $million
Table 58. Roche Diagnostics Limited - Company Snapshot
Table 59. Abbott Laboratories, Inc. - Company Snapshot
Table 60. Siemens AG, Becton - Company Snapshot
Table 61. Alere Inc. - Company Snapshot
Table 62. Dickinson and Company - Company Snapshot
Table 63. Beckman Coulter, Inc. - Company Snapshot
Table 64. Johnson & Johnson - Company Snapshot
Table 65. PTS Diagnostics - Company Snapshot
Table 66. Nova Biomedical - Company Snapshot
Table 67. Becton - Company Snapshot

LIST OF FIGURES

Figure 1. Point of Care Diagnostic: Glucose Monitoring Kits Market Value, 2014-2016, $million
Figure 2. Point of Care Diagnostic: Cardiometabolic Monitoring Kits Market Value, 2014-2016, $million
Figure 3. Point of Care Diagnostic: Cardiac Markers Market Value, 2014-2016, $million
Figure 4. Point of Care Diagnostic: Lipids Testing Market Value, 2014-2016, $million
Figure 5. Point of Care Diagnostic: Blood Gas/Electrolytes Testing Kits Market Value, 2014-2016, $million
Figure 6. Point of Care Diagnostic: HbA1c Testing Kits Market Value, 2014-2016, $million
Figure 7. Point of Care Diagnostic: Infectious Diseases Testing Kits Market Value, 2014-2016, $million
Figure 8. Point of Care Diagnostic: Influenza Testing Kits Market Value, 2014-2016, $million
Figure 9. Point of Care Diagnostic: HIV Testing Kits Market Value, 2014-2016, $million
Figure 10. Point of Care Diagnostic: Hepatitis C Testing Kits Market Value, 2014-2016, $million
Figure 11. Point of Care Diagnostic: Sexually-transmitted Diseases (STDs) Testing Kits Market Value, 2014-2016, $million
Figure 12. Point of Care Diagnostic: Tropical Diseases Testing Kits Market Value, 2014-2016, $million
Figure 13. Point of Care Diagnostic: Healthcare-associated Infections (HAIs) Market Value, 2014-2016, $million
Figure 14. Point of Care Diagnostic: Respiratory Infections Testing Kits Market Value, 2014-2016, $million
Figure 15. Point of Care Diagnostic: Others Infectious Diseases Testing Kits Market Value, 2014-2016, $million
Figure 16. Point of Care Diagnostic: Coagulation Monitoring Kits Market Value, 2014-2016, $million
Figure 17. Point of Care Diagnostic: Prothrombin Time (PT/INR) Testing Kits Market Value, 2014-2016, $million
Figure 18. Point of Care Diagnostic: Activated Clotting Time (ACT/APTT) Testing Kits Market Value, 2014-2016, $million
Figure 19. Point of Care Diagnostic: Pregnancy and Fertility Testing Kits Market Value, 2014-2016, $million
Figure 20. Point of Care Diagnostic: Pregnancy Testing Kits Market Value, 2014-2016, $million
Figure 21. Point of Care Diagnostic: Fertility Testing Kits Market Value, 2014-2016, $million
Figure 22. Point of Care Diagnostic: Tumor/Cancer Markers Market Value, 2014-2016, $million
Figure 23. Point of Care Diagnostic: Urinalysis Testing Kits Market Value, 2014-2016, $million
Figure 24. Point of Care Diagnostic: Cholesterol Test Strips Market Value, 2014-2016, $million
Figure 25. Point of Care Diagnostic: Hematology Testing Kits Market Value, 2014-2016, $million
Figure 26. Point of Care Diagnostic: Drugs of Abuse Testing Kits Market Value, 2014-2016, $million
Figure 27. Point of Care Diagnostic: Fecal Occult Testing Kits Market Value, 2014-2016, $million
Figure 28. Point of Care Diagnostic: Other Product Market Value, 2014-2016, $million
Figure 29. Point of Care Diagnostic: Prescription-based Testing Kits Market Value, 2014-2016, $million
Figure 30. Point of Care Diagnostic: Over-the-counter (OTC) Testing Kits Market Value, 2014-2016, $million
Figure 31. Point of Care Diagnostic: Professional Diagnostic Centers Market Value, 2014-2016, $million
Figure 32. Point of Care Diagnostic: Hospitals/Critical Care Centers Market Value, 2014-2016, $million
Figure 33. Point of Care Diagnostic: Outpatient Healthcare Settings Market Value, 2014-2016, $million
Figure 34. Point of Care Diagnostic: Ambulatory Care Settings Market Value, 2014-2016, $million
Figure 35. Point of Care Diagnostic: Research Laboratories Market Value, 2014-2016, $million
Figure 36. Point of Care Diagnostic: Home Care Market Value, 2014-2016, $million
Figure 37. Point of Care Diagnostic: Other End Users Market Value, 2014-2016, $million
Figure 38. Point of Care Diagnostic: U.S. Market Value, 2014-2016, $million
Figure 39. Point of Care Diagnostic: U.S. Market Value, 2017-2025, $million
Figure 40. Point of Care Diagnostic: Canada Market Value, 2014-2016, $million
Figure 41. Point of Care Diagnostic: Canada Market Value, 2017-2025, $million
Figure 42. Point of Care Diagnostic: Mexico Market Value, 2014-2016, $million
Figure 43. Point of Care Diagnostic: Mexico Market Value, 2017-2025, $million
Figure 44. Point of Care Diagnostic: UK Market Value, 2014-2016, $million
Figure 45. Point of Care Diagnostic: UK Market Value, 2017-2025, $million
Figure 46. Point of Care Diagnostic: Germany Market Value, 2014-2016, $million
Figure 47. Point of Care Diagnostic: Germany Market Value, 2017-2025, $million
Figure 48. Point of Care Diagnostic: France Market Value, 2014-2016, $million
Figure 49. Point of Care Diagnostic: France Market Value, 2017-2025, $million
Figure 50. Point of Care Diagnostic: Spain Market Value, 2014-2016, $million
Figure 51. Point of Care Diagnostic: Spain Market Value, 2017-2025, $million
Figure 52. Point of Care Diagnostic: Italy Market Value, 2014-2016, $million
Figure 53. Point of Care Diagnostic: Italy Market Value, 2017-2025, $million
Figure 54. Point of Care Diagnostic: Rest of Europe Market Value, 2014-2016, $million
Figure 55. Point of Care Diagnostic: Rest of Europe Market Value, 2017-2025, $million
Figure 56. Point of Care Diagnostic: China Market Value, 2014-2016, $million
Figure 57. Point of Care Diagnostic: China Market Value, 2017-2025, $million
Figure 58. Point of Care Diagnostic: Japan Market Value, 2014-2016, $million
Figure 59. Point of Care Diagnostic: Japan Market Value, 2017-2025, $million
Figure 60. Point of Care Diagnostic: India Market Value, 2014-2016, $million
Figure 61. Point of Care Diagnostic: India Market Value, 2017-2025, $million
Figure 62. Point of Care Diagnostic: Australia Market Value, 2014-2016, $million
Figure 63. Point of Care Diagnostic: Australia Market Value, 2017-2025, $million
Figure 64. Point of Care Diagnostic: South Korea Market Value, 2014-2016, $million
Figure 65. Point of Care Diagnostic: South Korea Market Value, 2017-2025, $million
Figure 66. Point of Care Diagnostic: Rest of Asia-Pacific Market Value, 2014-2016, $million
Figure 67. Point of Care Diagnostic: Rest of Asia-Pacific Market Value, 2017-2025, $million
Figure 68. Point of Care Diagnostic: Brazil Market Value, 2014-2016, $million
Figure 69. Point of Care Diagnostic: Brazil Market Value, 2017-2025, $million
Figure 70. Point of Care Diagnostic: Saudi Arabia Market Value, 2014-2016, $million
Figure 71. Point of Care Diagnostic: Saudi Arabia Market Value, 2017-2025, $million
Figure 72. Point of Care Diagnostic: South Africa Market Value, 2014-2016, $million
Figure 73. Point of Care Diagnostic: South Africa Market Value, 2017-2025, $million
Figure 74. Point of Care Diagnostic: Rest of LAMEA Market Value, 2014-2016, $million
Figure 75. Point of Care Diagnostic: Rest of LAMEA Market Value, 2017-2025, $million

COMPANIES MENTIONED

The top players in the global point of care diagnostics market include Roche Diagnostics Limited, Abbott Laboratories, Inc., Siemens AG, Becton, Alere Inc., Dickinson and Company, Beckman Coulter, Inc., Johnson & Johnson, PTS Diagnostics, and Nova Biomedical.


More Publications